Data / Form D filings / WATSON PHARMACEUTICALS INC
WATSON PHARMACEUTICALS INC: Form D filing
WATSON PHARMACEUTICALS INC, a pharmaceuticals company in Corona, CA, filed a Form D with the SEC in 2009. The latest, on December 10, 2009, reports $500 million sold of a $500 million offering.
Find out what WATSON PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 311 BONNIE CIRCLE, Corona, CA, 92880
- Phone
- (909) 270-1400
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 884629
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2009 | New notice | $500,000,000 | $500,000,000 | $0 | 0 | Dec 2, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| R. Todd M. Joyce | Executive Officer | |
| Ronald R. Taylor | Director | |
| Andrew L. Turner | Director | |
| Albert F. Hummel | Director | |
| David A. Buchen | Executive Officer | |
| Christopher W. Bodine | Director | |
| Anthony W. Tabatznik | Director | |
| Michael J. Fedida | Director | |
| Fred G. Weiss | Director | |
| Michel J. Feldman | Director | |
| Catherine M. Klema | Director | |
| Jack M. Michelson | Director | |
| Paul M. Bisaro | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 7, 2009 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what WATSON PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.